A 4-year fully-funded PhD studentship with Prof Mark Humphries and Dr JeYoung Yung at the University Of Nottingham is available to start September 2024. The project is titled 'Optimising patient selection for Deep Brain Stimulation in Parkinson’s disease using multimodal machine learning'. The goal of this project is to test how fusing clinical data, neuroimaging, and video assessments could optimise the selection of patients. The project will be in collaboration with MachineMedicine (London), a MedTech company specialising in Parkinson’s disease, and the movement disorders clinical team at St George’s Hospital, London. The PhD student will be trained in data-science and machine learning tools, including how to extract and analyse MRI and fMRI data, in fusing data across modalities, and in developing a machine-learning pipeline for predicting patient outcomes. These predictions will be tested against the 12-month follow-up data from the St George’s trial patients. The student’s further training will include a 3-month placement at MachineMedicine, and visits to St George’s clinic.

On Thursday February 15th, we will host Victoria Peterson and Julian Neumann. Victoria will tell us about “Spatial filtering to enhance signal processing in invasive neurophysiology”. Besides his scientific presentation on “Closed-loop deep brain stimulation as a neuroprosthetic of dopaminergic circuits – Current evidence and future opportunities”, Julian will give us a glimpse at the person behind the science. The talks will be followed by a shared discussion. Note: The talks will exceptionally be held at 10 ET / 4PM CET. You can register via talks.stimulatingbrains.org to receive the (free) Zoom link!

Seizure suppression by deep brain stimulation (DBS) applies high frequency stimulation (HFS) to grey matter to block seizures. In this presentation, I will present the results of a different method that employs low frequency stimulation (LFS) (1 to 10Hz) of white matter tracts to prevent seizures. The approach has been shown to be effective in the hippocampus by stimulating the ventral and dorsal hippocampal commissure in both animal and human studies respectively for mesial temporal lobe seizures. A similar stimulation paradigm has been shown to be effective at controlling focal cortical seizures in rats with corpus callosum stimulation. This stimulation targets the axons of the corpus callosum innervating the focal zone at low frequencies (5 to 10Hz) and has been shown to significantly reduce both seizure and spike frequency. The mechanisms of this suppression paradigm have been elucidated with in-vitro studies and involve the activation of two long-lasting inhibitory potentials GABAB and sAHP. LFS mechanisms are similar in both hippocampus and cortical brain slices. Additionally, the results show that LFS does not block seizures but rather decreases the excitability of the tissue to prevent seizures. Three methods of seizure suppression, LFS applied to fiber tracts, HFS applied to focal zone and stimulation of the anterior nucleus of the thalamus (ANT) were compared directly in the same animal in an in-vivo epilepsy model. The results indicate that LFS generated a significantly higher level of suppression, indicating LFS of white matter tract could be a useful addition as a stimulation paradigm for the treatment of epilepsy.

On Friday, August 31st we will host Stephanie Cernera & Doris Wang! Stephanie Cernera, PhD, is a postdoctoral research fellow in the Starr lab at University of California San Francisco. She will tell us about “Personalized chronic adaptive deep brain stimulation outperforms conventional stimulation in Parkinson’s Disease”. Doris Wang, MD, PhD, is a neurosurgeon and assistant professor at the University of California San Francisco. Apart from her scientific presentation about “Adaptive Deep Brain Stimulation to Treat Gait Disorders in Parkinson’s Disease”, she will give us a glimpse at the “Person behind the science”. The talks will be followed by a shared discussion. You can register via talks.stimulatingbrains.org to receive the (free) Zoom link!

On Thursday, May 25th we will host Darcy Diesburg and Mark Richardson. Darcy Diesburg, PhD, is a post-doctoral research fellow at Brown University. She will tell us about “Deep brain stimulation and action-stopping: A cognitive neuroscience perspective on the contributions of fronto-basal ganglia circuits to inhibitory control”. Mark Richardson, MD, PhD, is the Director of Functional Neurosurgery at the Massachusetts General Hospital, Charles Pappas Associate Professor of Neurosciences at Harvard Medical School and Visiting Associate Professor of Brain and Cognitive Sciences at MIT. Beside his scientific presentation on “Auditory input to the basal ganglia”, he will give us a glimpse at the “Person behind the science”. The talks will be followed by a shared discussion. You can register via talks.stimulatingbrains.org to receive the (free) Zoom link!

Why do we make decisions impulsively blinded in an emotionally rash moment? Or caught in the same repetitive suboptimal loop, avoiding fears or rushing headlong towards illusory rewards? These cognitive constructs underlying self-control and compulsive behaviours and their influence by emotion or incentives are relevant dimensionally across healthy individuals and hijacked across disorders of addiction, compulsivity and mood. My lab focuses on identifying theory-driven modifiable biomarkers focusing on these cognitive constructs with the ultimate goal to optimize and develop novel means of neuromodulation. Here I will provide a few examples of my group’s recent work to illustrate this approach. I describe a series of recent studies on intracranial physiology and acute stimulation focusing on risk taking and emotional processing. This talk highlights the subthalamic nucleus, a common target for deep brain stimulation for Parkinson’s disease and obsessive-compulsive disorder. I further describe recent translational work in non-invasive neuromodulation. Together these examples illustrate the approach of the lab highlighting modifiable biomarkers and optimizing neuromodulation.

Even if major depression is now the most common of psychiatric disorders, successful antidepressant treatments are still difficult to achieve. Therefore, a better understanding of the mechanisms of action of current antidepressant treatments is needed to ultimately identify new targets and enhance beneficial effects. Given the intimate relationships between astrocytes and neurons at synapses and the ability of astrocytes to "sense" neuronal communication and release gliotransmitters, an attractive hypothesis is emerging stating that the effects of antidepressants on brain function could be, at least in part, modulated by direct influences of astrocytes on neuronal networks. We will present two preclinical studies revealing a permissive role of glia in the antidepressant response: i) Control of the antidepressant-like effects of rat prefrontal cortex Deep Brain Stimulation (DBS) by astroglia, ii) Modulation of antidepressant efficacy of Bright Light Stimulation (BLS) by lateral habenula astroglia. Therefore, it is proposed that an unaltered neuronal-glial system constitutes a major prerequisite to optimize antidepressant efficacy of DBS or BLS. Collectively, these results pave also the way to the development of safer and more effective antidepressant strategies.

Over the last few decades, the use of deep brain stimulation (DBS) to improve the treatment of those with neurological movement disorders represents a critical success story in the development of invasive neurotechnology and the promise of brain-computer interfaces (BCI) to improve the lives of those suffering from incurable neurological disorders. In the last decade, investigational devices capable of recording and streaming neural activity from chronically implanted therapeutic electrodes has supercharged research into clinical applications of BCI, enabling in-human studies investigating the use of adaptive stimulation algorithms to further enhance therapeutic outcomes and improve future device performance. In this talk, Dr. Herron will review ongoing clinical research efforts in the field of adaptive DBS systems and algorithms. This will include an overview of DBS in current clinical practice, the development of bidirectional clinical-use research platforms, ongoing algorithm evaluation efforts, a discussion of current adoption barriers to be addressed in future work.

Studying the pathophysiology of late stage Parkinson’s disease (PD) – after the patients have experienced severe neuronal loss – has helped develop various symptomatic treatments for PD (e.g., deep brain stimulation). However, it has been of limited use in developing neuroprotective disease-modifying therapies (DMTs), because DMTs require interventions at much earlier stages of PD when vulnerable neurons are still intact. Because PD patients exhibit various non-motor prodromal symptoms (ie, symptoms that predate diagnosis), understanding the pathophysiology underlying these symptom could lead to earlier diagnosis and intervention. In my talk, I will present a recently elucidated example of how PD pathologies alter the channel biophysics of intact vagal motoneurons (known to be selectively vulnerable in PD) to drive dysautonomia that is reminiscent of prodromal PD. I will discuss how elucidating the pathophysiology of prodromal symptoms can lead to earlier diagnosis through the development of physiological biomarkers for PD.

In this webinar, Dr Ye Tian and A/Prof Andrew Zalesky will present new research on mapping the functional architecture of the human subcortex. They used 3T and 7T functional MRI from more than 1000 people to map one of the most detailed functional atlases of the human subcortex to date. Comprising four hierarchical scales, the new atlas reveals the complex topographic organisation of the subcortex, which dynamically adapts to changing cognitive demands. The atlas enables whole-brain mapping of connectomes and has been used to optimise targeting of deep brain stimulation. This joint work with Professors Michael Breakspear and Daniel Margulies was recently published in Nature Neuroscience. In the second part of the webinar, Dr Ye Tian will present her current research on the biological ageing of different body systems, including the human brain, in health and degenerative conditions. Conducted in more than 30,000 individuals, this research reveals associations between the biological ageing of different body systems. She will show the impact of lifestyle factors on ageing and how advanced ageing can predict the risk of mortality. Associate Professor Andrew Zalesky is a Principal Researcher with a joint appointment between the Faculties of Engineering and Medicine at The University of Melbourne. He currently holds a NHMRC Senior Research Fellowship and serves as Associate Editor for Brain Topography, Neuroimage Clinical and Network Neuroscience. Dr Zalesky is recognised for the novel tools that he has developed to analyse brain networks and their application to the study of neuropsychiatric disorders. Dr Ye Tian is a postdoctoral researcher at the Department of Psychiatry, University of Melbourne. She received her PhD from the University of Melbourne in 2020, during which she established the Melbourne Subcortex Atlas. Dr Tian is interested in understanding brain organisation and using brain imaging techniques to unveil neuropathology underpinning neuropsychiatric disorders.